Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/46030
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCameron L.A.-
dc.contributor.authorPhillips K.-
dc.contributor.authorMelvin G.A.-
dc.contributor.authorHastings R.P.-
dc.contributor.authorGray K.M.-
dc.date.accessioned2022-02-10T23:42:42Z-
dc.date.available2022-02-10T23:42:42Z-
dc.date.copyright2021-
dc.date.issued2021-09-05en
dc.identifier.citationBritish Journal of Psychiatry. 218(6) (pp 305-314), 2021. Date of Publication: June 2021.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/46030-
dc.description.abstractBackground Children and young people with intellectual disability and/or Autism Spectrum Disorder (autism) experience higher rates of mental health problems, including depression, than their typically developing peers. Although international guidelines suggest psychological therapies as first-line intervention for children and young people, there is limited evidence for psychological therapy for depression in children and young people with intellectual disability and/or autism. Aims To evaluate the current evidence base for psychological interventions for depression in children and young people with intellectual disability and/or autism, and examine the experiences of children and young people with intellectual disability and/or autism, their families and therapists, in receiving and delivering psychological treatment for depression. Method Databases were searched up to 30 April 2020 using pre-defined search terms and criteria. Articles were independently screened and assessed for risk of bias. Data were synthesised and reported in a narrative review format. Results A total of 10 studies met the inclusion criteria. Four identified studies were clinical case reports and six were quasi-experimental or experimental studies. All studies were assessed as being of moderate or high risk of bias. Participants with intellectual disability were included in four studies. There was limited data on the experiences of young people, their families or therapists in receiving or delivering psychological treatment for depression. Conclusions Well-designed, randomised controlled trials are critical to develop an evidence base for psychological treatment for young people with intellectual disability and/or autism with depression. Future research should evaluate the treatment experiences of young people, their families and therapists.Copyright © The Author(s), 2020. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.-
dc.publisherCambridge University Press-
dc.relation.ispartofBritish Journal of Psychiatry-
dc.subject.meshadolescent-
dc.subject.meshAsperger syndrome-
dc.subject.meshautism-
dc.subject.meshBeck Depression Inventory-
dc.subject.meshcognitive behavioral therapy-
dc.subject.meshdepression/dt [Drug Therapy]-
dc.subject.meshdepression/th [Therapy]-
dc.subject.meshdisease association-
dc.subject.meshdrug substitution-
dc.subject.meshdrug withdrawal-
dc.subject.meshdysthymia/th [Therapy]-
dc.subject.meshHamilton Depression Rating Scale-
dc.subject.meshintellectual impairment-
dc.subject.meshmajor depression/dt [Drug Therapy]-
dc.subject.meshmajor depression/th [Therapy]-
dc.subject.meshminor depression/th [Therapy]-
dc.subject.meshpediatric patient-
dc.subject.meshpsychotherapy-
dc.subject.meshrole playing-
dc.subject.meshtreatment duration-
dc.subject.meshtreatment outcome-
dc.subject.meshantidepressant agent/dt [Drug Therapy]-
dc.subject.meshantidepressant agent/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshchlorpromazine/cb [Drug Combination]-
dc.subject.meshchlorpromazine/dt [Drug Therapy]-
dc.subject.meshchlorpromazine/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshfluoxetine/cb [Drug Combination]-
dc.subject.meshfluoxetine/dt [Drug Therapy]-
dc.subject.meshfluoxetine/pv [Special Situation for Pharmacovigilance]-
dc.subject.mesholanzapine/cb [Drug Combination]-
dc.subject.mesholanzapine/dt [Drug Therapy]-
dc.subject.mesholanzapine/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshpsychotropic agent/dt [Drug Therapy]-
dc.subject.meshpsychotropic agent/pv [Special Situation for Pharmacovigilance]-
dc.titlePsychological interventions for depression in children and young people with an intellectual disability and/or autism: Systematic review.-
dc.typeReview-
dc.identifier.affiliationPsychologyen
dc.identifier.affiliationSpiritual Careen
dc.type.studyortrialSystematic review and/or meta-analysis-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1192/bjp.2020.226-
dc.publisher.placeUnited Kingdom-
dc.identifier.pubmedid33198825 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33198825]-
dc.identifier.institution(Cameron, Gray) Centre for Developmental Psychiatry and Psychology, Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Australiaen
dc.identifier.institution(Phillips, Gray) Discipline of Paediatrics, School of Women?s and Children?s Health, University of New South Wales Medicine, The University of New South Wales, Australiaen
dc.identifier.institution(Melvin) School of Psychology, Deakin University, Australiaen
dc.identifier.institution(Hastings, Gray) Centre for Education, Appraisal and Research, University of Warwick, United Kingdomen
dc.subect.keywordsadult-
dc.subect.keywordsfemale-
dc.subect.keywordshuman-
dc.subect.keywordsmale-
dc.subect.keywordsreview-
dc.subect.keywordssystematic review-
dc.identifier.affiliationext(Phillips, Gray) Discipline of Paediatrics, School of Women?s and Children?s Health, University of New South Wales Medicine, The University of New South Wales, Australia-
dc.identifier.affiliationext(Melvin) School of Psychology, Deakin University, Australia-
dc.identifier.affiliationext(Hastings, Gray) Centre for Education, Appraisal and Research, University of Warwick, United Kingdom-
dc.identifier.affiliationmh(Cameron, Gray) Centre for Developmental Psychiatry and Psychology, Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Australia-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeReview-
item.cerifentitytypePublications-
Appears in Collections:Articles
Show simple item record

Page view(s)

8
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.